Neurology, ophthalmology, orl

Version vom 21. Mai 2020, 18:20 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

32310553 2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)
32119409 2020. Neuroanatomy, Nucleus Gustatory PDF direct
32295727 ä. Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report
32343122 2020. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement
32320211 ä. Neurological Insights of COVID-19 Pandemic
C7160911 ä. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection
32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?
32167747 2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host?Virus Interaction, and Proposed Neurotropic Mechanisms
32233443 2020. Letter to the Editor ...Evidence of the COVID-19 Virus Targeting the CNS...
32367205 ä. SARS-CoV-2 can induce brain and spine demyelinating lesions
32377594 ä. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2
32278470 ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19)
32276732 ä. Hearing loss and COVID-19: A note
32327217 ä. COVID-19 and hearing difficulties
32345857 2020. COVID-19 and Neuroinvasion
32345855 2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm?
32265202 2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease
32362452 ä. The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19)
32240762 ä. Nervous system involvement after infection with COVID-19 and other coronaviruses
32360440 ä. Guillain-Barre syndrome as a complication of SARS-CoV-2 infection
32353521 ä. Potentially irreversible olfactory and gustatory impairments in COVID-19: indolent vs fulminant SARS-CoV-2 neuroinfection
32311495 ä. Nervous system damage after COVID-19 infection: presence or absence?
32335192 ä. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
32305574 ä. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020
32298803 ä. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms?
32283294 ä. Encephalitis as a clinical manifestation of COVID-19
32360439 ä. COVID-19 presenting as stroke
32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32283246 ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now
32284146 ä. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)

32357210 ä. Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
32215618 ä. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
32323704 2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis
32266761 2020. Neurological manifestations in COVID19 caused by SARS-CoV?2
32354654 ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy

32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32269598 2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32253535 ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
32328771 ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19
32303881 ä. Possible link between anosmia and COVID-19: sniffing out the truth
32309267 2020. Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
32329813 2020. Defining the burden of olfactory dysfunction in COVID-19 patients

32367431 ä. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain
32373061 2020. Triage of Acute Ischemic Stroke in Confirmed COVID-19: Large Vessel Occlusion Associated With Coronavirus Infection
32362868 2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
32333104 ä. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis
32328758 ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
32363146 2020. COVID-19 Presenting with Seizures
32313807 2020. Guillain-Barre Syndrome associated with SARS-CoV-2 infection
32373467 2020. Conjunctivitis can be the only presenting sign and symptom of COVID-19
32307026 ä. Olfactory and taste disorder: The first and only sign in a patient with SARS-CoV-2 pneumonia